Literature DB >> 15154625

Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma.

Naoki Yamanaka1, Nobuhiko Sasaki, Akira Tasaki, Hiroshi Nakashima, Makoto Kubo, Takashi Morisaki, Hirokazu Noshiro, Takashi Yao, Masazumi Tsuneyoshi, Masao Tanaka, Mitsuo Katano.   

Abstract

BACKGROUND: In common with other investigators, we have reported the constitutive activation of transcription factor nuclear factor-kappaB (NF-kappaB) in a variety of carcinomas, but there is no definite information on its clinical significance.
MATERIALS AND METHODS: NF-kappaB p65 activation was determined by immunohistochemical analysis of surgically resected specimens from 63 gastric carcinomas. The 63 patients were divided into a high NF-kappaB group (21 patients) and a low NF-kappaB group (42 patients). Forty-seven of the 63 patients underwent curative resection. The 47 patients consisted of 13 high NF-kappaB patients and 34 low NF-kappaB patients.
RESULTS: The high NF-kappaB group demonstrated a shorter overall survival rate compared with the low NF-kappaB group (p=0.015). In the 47 patients who underwent curative resection, the high NF-kappaB group also showed a poor survival prognosis (p=0.032). Multivariate analysis indicated that NF-kappaB activation is a potential prognostic factor in gastric carcinoma.
CONCLUSION: Constitutive activation of NF-kappaB p65 may be a new prognostic parameter in gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15154625

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  23 in total

1.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

2.  Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients.

Authors:  Fang Zhou; Hongjun Wei; Aiping Ding; Wensheng Qiu; Lingxin Feng; Quan Zhou; Jun Liang; Lu Yue
Journal:  Clin Transl Sci       Date:  2013-05-08       Impact factor: 4.689

3.  Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice.

Authors:  Koichiro Haruki; Hiroaki Shiba; Yuki Fujiwara; Kenei Furukawa; Ryota Iwase; Tadashi Uwagawa; Takeyuki Misawa; Toya Ohashi; Katsuhiko Yanaga
Journal:  Dig Dis Sci       Date:  2012-07-18       Impact factor: 3.199

4.  Co-expression of β-arrestin1 and NF-кB is associated with cancer progression and poor prognosis in lung adenocarcinoma.

Authors:  Jianyu Yu; Liguang Wang; Tiehong Zhang; Hongchang Shen; Wei Dong; Yang Ni; Jiajun Du
Journal:  Tumour Biol       Date:  2015-03-28

5.  A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma.

Authors:  Manish A Shah; Derek G Power; Hedy L Kindler; Kyle D Holen; Margaret M Kemeny; David H Ilson; Laura Tang; Marinela Capanu; John J Wright; David P Kelsen
Journal:  Invest New Drugs       Date:  2010-06-25       Impact factor: 3.850

Review 6.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

7.  Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.

Authors:  Jing Li; Lin Shen; Fu-rong Lu; You Qin; Rui Chen; Jia Li; Yan Li; Han-zi Zhan; Yuan-qiao He
Journal:  Acta Pharmacol Sin       Date:  2012-01-09       Impact factor: 6.150

Review 8.  Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies.

Authors:  Sahil Gambhir; Dinesh Vyas; Michael Hollis; Apporva Aekka; Arpita Vyas
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

9.  Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance.

Authors:  Georgia Levidou; Penelope Korkolopoulou; Nikolaos Nikiteas; Nikolaos Tzanakis; Irene Thymara; Angelica A Saetta; Christos Tsigris; George Rallis; Konstantin Vlasis; Efstratios Patsouris
Journal:  Virchows Arch       Date:  2007-04-12       Impact factor: 4.064

10.  Nuclear factor kappa B: a marker of chemotherapy for human stage IV gastric carcinoma.

Authors:  You-Ming Long; Sheng Ye; Jian Rong; Wen-Rui Xie
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.